METHREXX sol inj 15 mg/0.75ml ser pré 0.75 ml
7680620830145
CH-62083
L04AX03
07.10.6.
Reimbursement limitations:
METHREXX
N’est pas remboursé dans l’indication suivante: Formes légères à modérées de la maladie de Crohn, …
1 / 3
google
Details
- Product number
- 6208315
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- methotrexatum 15 mg ut methotrexatum natricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 3.097 mg. Tela cum: alcohol isopropylicus.
Articles (1)
Methrexx 15 mg/0.75 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
TEL
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.097 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 36.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2016
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62083
- Drug name
- Methrexx, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AX03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/06/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.10.6.
- Domain
- Human medicine
Packaging details
- Description (FR)
- METHREXX sol inj 15 mg/0.75ml ser pré 0.75 ml
- Description (DE)
- METHREXX Inj Lös 15 mg/0.75ml Fertspr 0.75 ml
- Market launch
- 06/07/2015
- Narcotic (BTM)
- No